Location History:
- Berlin, DE (2005 - 2009)
- Bergfelde, DE (2013 - 2017)
- OT Bergfelde, DE (2016 - 2017)
- Hohen Neuendorf, DE (2019 - 2020)
- OT Bergf, DE (2016 - 2022)
Company Filing History:
14 out of 378 
8 out of 721 
2 out of 1,384 
Years Active: 2005-2025
Title: Volker Schulze: Innovator in Pharmaceutical Compounds
Introduction
Volker Schulze, based in OT Bergf, Germany, is a prominent inventor with a remarkable portfolio of 24 patents. His work primarily focuses on innovative pharmaceutical compounds, demonstrating his significant contribution to the field of medicinal chemistry.
Latest Patents
Among Schulze's latest inventions are notable patents involving 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors. This invention describes processes for producing compounds that serve as inhibitors of Casein kinase 1 alpha and/or delta (CSNK1α and/or β), which are essential for the treatment of proliferative disorders. Additionally, he has developed 4H-pyrrolo[3,2-c]pyridin-4-one derivatives, showcasing the versatility and applicability of his inventions in the pharmaceutical industry.
Career Highlights
Schulze's career includes significant roles at Bayer Pharma Aktiengesellschaft and Bayer Intellectual Property GmbH. His tenure at these reputable organizations has allowed him to refine his skills in both research and the intellectual property management of scientific innovations.
Collaborations
Throughout his career, Schulze has worked alongside notable colleagues such as Philip Lienau and Knut Eis. These collaborations have undoubtedly enhanced his research capabilities and broadened the scope of his innovative contributions to the field.
Conclusion
Volker Schulze stands out as a significant figure in the innovation landscape, particularly in the realm of pharmaceuticals. With 24 patents to his name, his work continues to pave the way for advances in medical treatments, showcasing the importance of innovation in addressing complex health challenges.